Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
46.92 USD | +0.45% | -5.73% | -12.46% |
07/05 | DA Davidson Adjusts Price Target on USANA Health Sciences to $46 From $48, Maintains Neutral Rating | MT |
01/05 | Transcript : USANA Health Sciences, Inc., Q1 2024 Earnings Call, May 01, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.46% | 894M | |
+13.74% | 8.18B | |
+5.29% | 7.53B | |
-0.42% | 5.89B | |
-6.67% | 3.7B | |
-10.75% | 3.57B | |
-8.21% | 1.26B | |
-29.10% | 1.08B | |
+14.92% | 991M | |
-17.68% | 794M |
- Stock Market
- Equities
- USNA Stock
- News USANA Health Sciences, Inc.
- USANA Health Sciences CEO Kevin Guest to Transition to Executive Chairman Role; Jim Brown, President, Named CEO of Company